Condakes, M. L., Zhang, Z., Danahy, D. B., Moore, R. R., Lakkaraju, S. K., Zhuo, X., Amako, Y., Borzilleri, R. M., Balachander, S. B., Chourb, L., Civiello, R. L., Dongre, A. R., Downes, D. P., Drexler, D. M., Dudiak, B. M., Dzhekieva, L., El-Samin, M., Fink, B. E., Frederick, K., Huang, C., Khan, J., Lees, E., Levins, C. G., McCarthy, C., Mintier, G. A., Mosure, K., Parker, M. F., Powles, R., Qi, J., Ruzanov, M., Sharma, S., Sheriff, S., Singh, A. K., Stedman, J., Szapiel, N., Thompson, R. L., Vaccaro, W., Wang, T., Yang, T., You, D., Meyer, M. J., Bronson, J. J., Stewart, M. L. (2026). Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12C. Nature Communications. https://doi.org/10.1038/s41467-026-69003-0